Health & Medicine - Thursday, October 22, 2009 13:23 - 3 Comments

Compound appears to slow ALS progression

Berislav Zlokovic is part of a team working to develop a therapy to treat Lou Gehrig’s disease.

U. ROCHESTER (US)—A chemical cousin of a drug currently used to treat sepsis dramatically slows the progression of amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig’s disease, in mice. Continue…